Stereotaxis invites virtual test drives of new robotic EP technology

Stereotaxis invites virtual test drives of new robotic EP technology
Stereotaxis launches virtual test drive

Stereotaxis is now offering virtual test drives of its newest robotic electrophysiology (EP) technology. The company encourages interested individuals to request a seat for a remote demonstration of its latest innovations.

This initiative allows potential users to engage with Stereotaxis technology from home, reflecting the company's commitment to accessibility and interactive product exploration.

Stereotaxis recently reported the treatment of 70 patients since its July launch, addressing a broad range of arrhythmia cases and prior failed procedures, according to company disclosures. The company continues to develop its portfolio of robotic electrophysiology technology. This follows ongoing efforts to expand clinical accessibility and technology adoption.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.